INTERNATIONAL PATENT: ASTRAZENECA UK LIMITED, DAIICHI SANKYO COMPANY, LIMITED FILES APPLICATION FOR "COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ANTI-PD-1/TIM-3 BISPECIFIC BINDING PROTEIN"

GENEVA, May 5 -- ASTRAZENECA UK LIMITED (1 Francis Crick AvenueCambridge Biomedical CampusCambridge CB2 0AA), DAIICHI SANKYO COMPANY, LIMITED (3-5-1, Nihonbashi HonchoChuo-kuTokyo 103-8426) filed a patent application (PCT/IB2024/060392) for "COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ANTI-PD-1/TIM-3 BISPECIFIC BINDING PROTEIN" on Oct 23, 2024. With publication no. WO/2025/088496, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SUNG, Matthew Simon (c/o AstraZeneca Pharmaceuticals LP1800 Concord Pike, P.O. Box 15437Wilmingt...